4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000095
EVP, Chf Clinical Develop Ofcr sold 1,413 shares at $40.67 ($57,464)
- EVP, Chf Clinical Develop Ofcr acquired 4,033 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Schneider Eugene · EVP, Chf Clinical Develop Ofcr
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-03 | Grant or award : show line 1 in the form | +4,033 | 26,359 | D | ||
| 2023-02-06 | Sale : show line 2 in the form | −1,413 | $40.67 | $57,464 | 24,946 | D |
| Open-market sales · 1,413 sh · avg $40.67 · $57,464 | ||||||
Loading xslF345X03/edgardoc.xml…